As everyone knew, serum alpha fetoprotein (AFP), as a carcinoembryonic glycoprotein, was the first to be studied as a biomarker of hepatocellular carcinoma by Abelev in 1968 [14]. This evidence concerns the gene AFP and hepatocellular carcinoma.